Market Cap

Arbutus Biopharma Corporation Market Capitalization:

$917.4 Million

USD as of Jan. 1, 2026

business Arbutus Biopharma Corporation Company Profile

Arbutus Biopharma Corporation Main Stock Listing

NASDAQ: ABUS

Market Capitalization History of Arbutus Biopharma Corporation

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Arbutus Biopharma Corporation market cap

Date Market Cap YoY Change
Jan. 1, 2026 $917.4 M 45.82%
Jan. 1, 2025 $629.1 M 50.66%
Jan. 1, 2024 $417.6 M -6.98%
Jan. 1, 2023 $448.9 M -5.69%
Jan. 1, 2022 $476.0 M -25.66%
Jan. 1, 2021 $640.3 M 44.83%
Jan. 1, 2020 $442.1 M -29.27%
Jan. 1, 2019 $625.0 M -27.65%
Jan. 1, 2018 $863.9 M 92.45%
Jan. 1, 2017 $448.9 M -15.61%
Jan. 1, 2016 $531.9 M -87.74%
Jan. 1, 2015 $4.34 B 83.45%
Jan. 1, 2014 $2.36 B 197.02%
Jan. 1, 2013 $796.1 M 125.96%
Jan. 1, 2012 $352.3 M -64.86%
Jan. 1, 2011 $1.00 B 57.87%
Jan. 1, 2010 $635.2 M 41.51%
Jan. 1, 2009 $448.9 M -43.62%
Jan. 1, 2008 $796.1 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Arbutus Biopharma Corporation Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Arbutus Biopharma Corporation has the following listings and related stock indices.


Stock: NASDAQ: ABUS

Stock: FSX: I9DN

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.